Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 106151
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106151
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.106151
Figure 7 Clinical significance of E2F transcription factor 1 dysregulation in hepatocellular carcinoma: Expression patterns and survival implications.
A: Transcriptional overexpression of E2F transcription factor 1 (E2F1) mRNA in hepatocellular carcinoma vs non-tumorous liver tissues; B–D: Prognostic stratification using Kaplan–Meier Plotter survival analytics including overall survival, progression-free survival, recurrence-free survival (log-rank P < 0.01). E2F1: E2F transcription factor 1; OS: Overall survival; PFS: Progression-free survival; RFS: Recurrence-free survival.
- Citation: Liu R, Li JC, Li SD, Li JD, He RQ, Chen G, Feng ZB, Wei JL. Deciphering the oncogenic role of Rac family small GTPase 3 in hepatocellular carcinoma through multiomics integration. World J Hepatol 2025; 17(7): 106151
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/106151.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.106151